Related Experiment Video
Updated: Sep 17, 2025
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
The Association of Polymorphisms in Interleukin-6 (IL-6), Interleukin-10 (IL-10), IL-6 Receptor, and IL-10 Receptor
Paulina Krawiec1, Monika Lejman2, Elżbieta Pac-Kożuchowska1
1Department of Pediatrics and Gastroenterology, Medical University of Lublin, Lublin, 20-059, Poland.
Purpose:
Inflammatory bowel disease (IBD) results from a complex interplay between genetic, immune, and environmental factors. Despite a significant advancement in genetic studies, until now, little is known about genotype-phenotype correlations in children with IBD. Thus, we aimed to evaluate if polymorphisms in the Interleukin-6 (IL-6), Interleukin-10 (IL-10), IL-6 receptor, and IL-10 receptor genes are associated with the risk for pediatric IBD, its phenotype and severity.
Patients And Methods:
We enrolled 50 children with IBD in the study group and 20 healthy children to the control group. Demographic and clinical data of the subjects were collected from available electronic medical records. The DNA was extracted from peripheral blood samples of all individuals. TaqMan® single nucleotide polymorphism (SNP) genotyping assays were used to detect IL-10 variants RS3024505 and RS1800872, IL-10RA RS3135932, IL-10RB RS2834167, IL-6 RS10499563, and IL-6R RS4537545. A binary logistic regression model was used to evaluate the association between SNP's and the risk of IBD, IBD onset, phenotype, and the need to use of steroids or biologics.
Results:
There was a significant difference in the genotype distribution of IL-6 RS10499563 between patients with IBD and control group (χ2 = 10.96, p = 0.004). The distribution of genotype CT at IL-6 RS10499563 was higher, whereas the distribution of genotype CC and TT at IL-6 RS10499563 was lower in children compared to controls. There were no significant differences in the distribution of the other SNPs between the study and control groups. We found a significant association between the genotype CT at IL-6 RS10499563 and the risk of ulcerative colitis (OR 13.41; 95% CI: 1.58-114.26; p = 0.02), but not Crohn's disease (OR 7.60; 95% CI: 0.82-70.16; p = 0.07).
Conclusion:
In this study, we found a significant association between the genotype CT at IL-6 RS10499563 and the risk of ulcerative colitis in children.
Related Concept Videos
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...